Cholangiocarcinoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

No FDA or trial events recorded yet for Cholangiocarcinoma.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

2

Total programs

2

Open now

1

Copay cards

Copay Assistance1

PEMAZYRE

Incyte

OpenContact for detailsApply ↗

Patient Assistance Programs1

Blenoxane

Bristol-Myers Squibb Pharmaceutical Research Institute

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

PEMAZYRE

(Pemigatinib)Orphan drugaccelerated

Incyte Corporation

Kinase Inhibitor [EPC]

12.1 Mechanism of Action Pemigatinib is a small molecule kinase inhibitor that targets FGFR1, 2 and 3 with IC 50 values of less than 2 nM. Pemigatinib...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Cholangiocarcinoma.
Search all trials →
Search clinical trials for Cholangiocarcinoma

Recent News & Research

No recent news articles indexed yet for Cholangiocarcinoma.
Search PubMed for Cholangiocarcinoma

Browse all Cholangiocarcinoma news →

Specialist Network

Top 6 by expertise

View all Cholangiocarcinoma specialists →

Quick Actions